6-Mercaptopurine-related pancreatitis in 2 patients with inflammatory bowel disease.
Two patients with inflammatory bowel disease who developed acute pancreatitis within 21 days of commencing treatment with 6-mercaptopurine are presented. Both were inadvertently reexposed to the drug and developed recurrent pancreatitis within 3 hr of a single dose.
D000208:Acute Disease; D000328:Adult; D003093:Colitis, Ulcerative / Q000150:complications*; D003424:Crohn Disease / Q000150:complications*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects*; D010195:Pancreatitis / Q000139:chemically induced*; D012008:Recurrence
D015122:Mercaptopurine